Shedding old paradigms: Developing viruses to treat cancer

被引:9
作者
Bergsland, EK [1 ]
Venook, AP [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
D O I
10.1200/JCO.2002.20.9.2220
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2220 / 2222
页数:3
相关论文
共 13 条
[1]   Replicative adenoviruses for cancer therapy [J].
Alemany, R ;
Balagué, C ;
Curiel, DT .
NATURE BIOTECHNOLOGY, 2000, 18 (07) :723-727
[2]   Interleukin 12 secretion enhances antitumor efficacy of oncolytic herpes simplex viral therapy for colorectal cancer [J].
Bennett, JJ ;
Malhotra, S ;
Wong, RJ ;
Delman, K ;
Zager, J ;
St-Louis, M ;
Johnson, P ;
Fong, Y .
ANNALS OF SURGERY, 2001, 233 (06) :819-826
[3]  
Heise C, 2000, CLIN CANCER RES, V6, P4908
[4]   Replication-selective virotherapy for cancer: Biological principles, risk management and future directions [J].
Kirn, D ;
Martuza, RL ;
Zwiebel, J .
NATURE MEDICINE, 2001, 7 (07) :781-787
[5]   Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned? [J].
Kirn, D .
GENE THERAPY, 2001, 8 (02) :89-98
[6]  
Mani S, 1997, SEMIN ONCOL, V24, P253
[7]   Impact of body-size measures on irinotecan clearance: Alternative dosing recommendations [J].
Mathijssen, RHJ ;
Verweij, J ;
de Jonge, MJA ;
Nooter, K ;
Stoter, G ;
Sparreboom, A .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :81-87
[8]  
Nemunaitis J, 2000, CANCER RES, V60, P6359
[9]   Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers [J].
Pecora, AL ;
Rizvi, N ;
Cohen, GI ;
Meropol, NJ ;
Sterman, D ;
Marshall, JL ;
Goldberg, S ;
Gross, P ;
O'Neil, JD ;
Groene, WS ;
Roberts, MS ;
Rabin, H ;
Bamat, MK ;
Lorence, RM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (09) :2251-2266
[10]   Therapeutic replication-competent herpes virus [J].
Rampling, R ;
Cruickshank, G ;
MacLean, A ;
Brown, M .
NATURE MEDICINE, 1998, 4 (02) :133-133